Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Cells|November 8, 2024
Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging TargetClément Klein, Samy Mebroukine, Mathilde Madéry, et al.Cancer Medicine|February 12, 2019
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cellsLucas Touzet, Florent Dumezy, Christophe Roumier, et al.Cytometry. Part B, Clinical Cytometry|April 16, 2025
Detection of circulating tumor cells is achieved by flow cytometry in melanoma patientsLudivine Fourdrain, Théo Brochet, Valentin Clichet, et al.International Journal of Laboratory Hematology|September 4, 2024
Evaluation of the immature platelet fraction as a predictive marker of bone marrow regeneration after hematopoietic stem cell transplantationKélian Steibel, Magalie Joris, Valentin Clichet, et al.Current Research in Translational Medicine|November 21, 2021
Beneficial outcomes and epidemiologics of atypical electrophoretic profiles arising after allogeneic hematopoietic stem cell transplantation for myeloid malignanciesKaies Hedhli, Valentin Clichet, Amandine Charbonnier, et al.Haematologica|March 16, 2023
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometryValentin Clichet, Delphine Lebon, Nicolas Chapuis, et al.Journal of Visualized Experiments : Jove|April 10, 2018
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow UpThomas Boyer, Fanny Gonzales, Adriana Plesa, et al.Ebiomedicine|August 20, 2022
Combining imaging flow cytometry and machine learning for high-throughput schistocyte quantification: A SVM classifier development and external validation cohortJulien Demagny, Camille Roussel, Maïlys Le Guyader, et al.International Journal of Molecular Sciences|August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia TreatmentLaurène Fenwarth, Elise Fournier, Meyling Cheok, et al.Gastroenterology|May 13, 2008
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeArun J Sanyal, Thomas Boyer, Guadalupe Garcia-Tsao, et al.Pageof 5